|
|
|
|
|
07.11.25 - 18:01
|
ASP Isotopes Jumps After Investment By Trump′s Boys (ZeroHedge)
|
|
|
ASP Isotopes Jumps After Investment By Trump's Boys
One month ago we discussed why isotope-developer ASP Isotopes (ASPI) is emerging as one of the nascent "nuclear" plays to provide fuel for the AI energy renaissance. It appears that Trump's kids read what we wrote.
This morning, just before the open, ASP Isotopes (ASPI) announced a private placement for convertible notes of their advanced materials subsidiary Quantum Leap Energy (QLE), in which investors would be none other than the Trump boys.
Eric and Donald Jr participated in the private placement led by American Ventures LLC (a fund run by Dominari Holdings CEO Soo Yu which has done work with the Trumps before) and ASPI for over $60 million of convertible notes for QLE. The subsidiary is due to be spun out of ASPI by the end of the year. An update on official dates is expected to be provided in the earnings report coming up on November 18th.
Source
QLE is developing the technology for enriching select isotopes with lasers, said to be si...
|
|
|
07.11.25 - 15:33
|
Quantum Leap Energy LLC Announces Private Placement of Convertible Notes Led by American Ventures LLC (GlobeNewswire EN)
|
|
|
WASHINGTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Quantum Leap Energy LLC (“QLE”), a wholly-owned subsidiary of ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced that QLE has commenced an offering of QLE's convertible notes in a private placement to accredited investors and certain non-U.S. persons. QLE has entered into a definitive convertible note purchase agreement with certain investors for an initial closing of US$64.3 million aggregate principal amount of QLE's convertible notes (the "Notes")....
|
|
|
|
|
|
|
15.10.25 - 13:03
|
ASP Isotopes Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire EN)
|
|
|
WASHINGTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the pricing of an underwritten public offering of 17,167,380 shares of its common stock for total gross proceeds of approximately $210.3 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The offering is expected to close on October 16, 2025, subject to satisfaction of customary closing conditions. All of the shares of common stock in the offering will be sold by the Company....
|
|
|
|
|
|
|
|
|
14.10.25 - 22:21
|
ASP Isotopes Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire EN)
|
|
|
WASHINGTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering....
|
|
|
13.10.25 - 19:54
|
The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition (ZeroHedge)
|
|
|
The Next Nuclear Story Stock: ASP Isotopes Shares Surge After Supply Contract For Silicon-28 And U.S. Radiopharmacy Acquisition
ASP Isotopes, a name we pointed out to our subscribers about one week ago, is up more than 13% this morning after it issued a business update that highlights how well-positioned it is across both technology and medical applications.
ASP announced its largest-ever supply contract for enriched silicon-28 and a strategic acquisition of a U.S.-based radiopharmacy — two moves that deepen its exposure to the fast-growing quantum computing and nuclear medicine markets.
LEU just hit $400.
For those looking for a cheap uranium enrichment alternative, we told subs 1 week ago to go long ASPI. It's starting to move. https://t.co/i1t7vf3bdl
— zerohedge (@zerohedge) October 10, 2025
This morning the company said it “entered into a supply contract with a U.S.-based customer for enriched silicon-28, with deliveries expected during Q1 2026,” calling it “the Company's lar...
|
|
|
13.10.25 - 14:18
|
ASP Isotopes Provides Business Updates (GlobeNewswire EN)
|
|
|
WASHINGTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided a business development update, including a supply agreement for the largest quantity of enriched silicon-28 received by the Company to date and a strategic acquisition of a radiopharmacy in the United States to complement and expand the operations of PET Labs Pharmaceuticals (Pty) Ltd (“PET Labs”), the Company's South African radiopharmaceutical operations company, dedicated to nuclear medicine and the science of radiopharmaceutical production....
|
|
|
|
|
|
|
|
|
02.09.25 - 13:33
|
ASP Isotopes Issues Letter to Shareholders (GlobeNewswire EN)
|
|
|
WASHINGTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today released the following letter to shareholders from its Chairman and CEO, Paul Mann....
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
